FLT4 and neoplasm: Alishekevitz, et al. recently provided evidence suggesting that paclitaxel, a member of the taxane-based chemotherapy family, promotes VEGFR3+ macrophage homing to treated tumor sites and that this may lead to increased Lyve1+ staining in tissues [20].